Related Experiment Video
Updated: Jun 5, 2026

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
Published on: March 30, 2018
[Progressive multifocal leukoencephalopathy after rituximab therapy in a patient with mantle cell lymphoma]
Ikuyo Ota1, Yukitaka Katsura, Chikashi Yoshida
1Department of Hematology, National Hospital Organization Mito Medical Center, Japan.
Abstract:
A 74-year-old man, who had mantle cell lymphoma treated with several anticancer drugs including rituximab, was admitted to our hospital because of gait disturbance and progressive paralysis of the right lower limb. T2-weighted MR image showed multiple high intensity lesions in the left parietal lobe. Suspected of being cerebral invasion of lymphoma, high-dose methotrexate was begun, but the patient died of sepsis without neurological improvement. At autopsy, it was proven that neurological symptoms had been caused by progressive multifocal leukoencephalopathy (PML). PML should be considered as a possible complication of heavily treated lymphoma.